This research study is evaluating the combination of two drugs, copanlisib and venetoclax, as
a possible treatment for trelapsed/refractory diffuse large B-cell lymphoma (DLBCL)
The names of the study drugs involved in this study are:
- Copanlisib
- Venetoclax